Stock comparison
BlackRock Technology and Private Equity Term
ResMed
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BTX
BlackRock Technology and Private Equity Term
Market cap
$1.04B
Sector
Healthcare
RMD
ResMed
Market cap
$30.18B
Sector
Healthcare
Overall winner
ResMed RMD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BTX | RMD | Winner |
|---|---|---|---|
| Warren Buffett | 44D | 72B | RMD |
| Benjamin Graham | 46D | 75B | RMD |
| Philip Fisher | 62C | 75B | RMD |
| Peter Lynch | 56C | 58C | RMD |
| Joel Greenblatt | 44D | 47D | RMD |
| Charlie Munger | 41D | 69B | RMD |
| Terry Smith | 45D | 73B | RMD |
Side-by-side metrics
| Metric | BTX | RMD |
|---|---|---|
| Market cap | $1.04B | $30.18B |
| P/E (TTM) | 50.0x | 19.6x |
| EV/EBIT | 27.0x | 17.1x |
| ROIC (TTM) | 3.85% | 19.63% |
| Gross margin | 100.0% | 61.69% |
| Net margin | 87.75% | 27.44% |
| Revenue CAGR 5y | - | 12.64% |
| EPS CAGR 5y | - | 30.73% |
| Debt / Equity | - | 0.1x |
| Dividend yield | 9.29% | 1.14% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BTX leads on
- Debt / Equity-vs 0.1x+100%
- Dividend yield9.29%vs 1.14%+88%
- Net margin87.75%vs 27.44%+69%
- Gross margin100.0%vs 61.69%+38%
RMD leads on
- Market cap$30.18Bvs $1.04B+97%
- ROIC (TTM)19.63%vs 3.85%+80%
- P/E (TTM)19.6xvs 50.0x+61%
- EV/EBIT17.1xvs 27.0x+37%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.